National Centre for Neurosurgery, Beaumont Hospital, Dublin, Ireland.
School of Medicine, University College Dublin, Dublin, Ireland.
Acta Neurochir (Wien). 2021 May;163(5):1423-1435. doi: 10.1007/s00701-021-04809-z. Epub 2021 Mar 23.
Decompressive craniectomy (DC) is a common neurosurgical intervention for severe traumatic brain injury (TBI), as well as malignant stroke, malignancy and infection. DC necessitates subsequent cranioplasty. There are significant demographic differences between TBI and non-TBI patients undergoing cranioplasty, which may influence their relative risk profiles for infection, aseptic bone flap resorption (aBFR) and re-operation.
Perform a meta-analysis to determine the relative infection, aBFR and re-operation risk profiles of TBI patients as compared to other indications for DC.
A systematic review and meta-analysis was performed in accordance with the PRISMA guidelines. PubMed, MEDLINE, EMBASE and Google Scholar were searched until 26/11/2020. Studies detailing rates of infection, re-operation and/or aBFR in specific materials and the post-TBI population were included, while studies in paediatrics or craniosynostosis repair were excluded.
Twenty-six studies were included. There was no difference in relative risk of infection between TBI and non-TBI cohorts (RR 0.81, 95% CI 0.57-1.17), with insignificant heterogeneity (I = 33%). TBI was a risk factor for aBFR (RR 1.54, 95% CI 1.25-1.89), with no significant heterogeneity (I = 13%). TBI was a risk factor for re-operation in the autologous sub-group (RR 1.49, 95% CI 1.05-2.11) but not in the alloplastic sub-group (RR = 0.86, 95% CI 0.34-2.18). Heterogeneity was insignificant (I = 11%).
TBI is a risk factor for aBFR and re-operation following cranioplasty. Use of an alloplastic graft for primary cranioplasty in these patients may partially mitigate this increased risk.
去骨瓣减压术(DC)是治疗严重创伤性脑损伤(TBI)、恶性中风、恶性肿瘤和感染的常见神经外科干预措施。DC 需要随后进行颅骨修复术。接受颅骨修复术的 TBI 患者和非 TBI 患者之间存在显著的人口统计学差异,这可能会影响他们感染、无菌性骨瓣吸收(aBFR)和再次手术的相对风险特征。
进行荟萃分析,以确定 TBI 患者与 DC 的其他适应证相比,感染、aBFR 和再次手术的相对风险特征。
根据 PRISMA 指南进行系统评价和荟萃分析。检索 PubMed、MEDLINE、EMBASE 和 Google Scholar,截至 2020 年 11 月 26 日。纳入详细描述特定材料和 TBI 后人群感染、再次手术和/或 aBFR 发生率的研究,排除儿科或颅缝早闭修复的研究。
共纳入 26 项研究。TBI 和非 TBI 队列之间的感染相对风险无差异(RR 0.81,95%CI 0.57-1.17),异质性不显著(I = 33%)。TBI 是 aBFR 的危险因素(RR 1.54,95%CI 1.25-1.89),异质性不显著(I = 13%)。TBI 是自体亚组再次手术的危险因素(RR 1.49,95%CI 1.05-2.11),但不是同种异体亚组的危险因素(RR = 0.86,95%CI 0.34-2.18)。异质性不显著(I = 11%)。
TBI 是颅骨修复术后 aBFR 和再次手术的危险因素。在这些患者中,使用同种异体移植物进行初次颅骨修复术可能会部分降低这种增加的风险。